Trademark: 90351179
Word
DIALA
Status
Registered
Status Code
700
Status Date
Tuesday, July 26, 2022
Serial Number
90351179
Registration Number
6800054
Registration Date
Tuesday, July 26, 2022
Mark Type
4000
Filing Date
Tuesday, December 1, 2020
Published for Opposition
Tuesday, May 10, 2022

Trademark Owner History
D&D Biopharmaceuticals Inc. - Original Registrant

Classifications
5 A system for eye dilation comprised of ophthalmic solutions

Trademark Events
Nov 15, 2023
Teas Change Of Correspondence Received
Nov 15, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 15, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Nov 15, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Nov 15, 2023
Teas Change Of Owner Address Received
Jul 26, 2022
Notice Of Registration Confirmation Emailed
Jul 26, 2022
Registered-Principal Register
May 10, 2022
Official Gazette Publication Confirmation E-Mailed
May 10, 2022
Published For Opposition
Apr 20, 2022
Notification Of Notice Of Publication E-Mailed
Apr 7, 2022
Approved For Pub - Principal Register
Mar 4, 2022
Teas/Email Correspondence Entered
Mar 4, 2022
Correspondence Received In Law Office
Mar 4, 2022
Teas Request For Reconsideration Received
Oct 9, 2021
Notice Of Acceptance Of Amendment To Allege Use E-Mailed
Oct 8, 2021
Use Amendment Accepted
Sep 4, 2021
Notification Of Final Refusal Emailed
Sep 4, 2021
Final Refusal E-Mailed
Sep 4, 2021
Final Refusal Written
Aug 3, 2021
Teas/Email Correspondence Entered
Aug 3, 2021
Correspondence Received In Law Office
Aug 3, 2021
Teas Response To Office Action Received
Aug 3, 2021
Teas Response To Office Action Received
May 7, 2021
Notification Of Non-Final Action E-Mailed
May 7, 2021
Non-Final Action E-Mailed
May 7, 2021
Non-Final Action Written
Apr 30, 2021
Assigned To Examiner
Mar 5, 2021
Amendment To Use Processing Complete
Mar 5, 2021
Use Amendment Filed
Mar 4, 2021
Teas Amendment Of Use Received
Feb 5, 2021
New Application Office Supplied Data Entered
Dec 4, 2020
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24